# clm_223CF07E8DCB

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 1,382,000,000 United States dollar  
valid_from: 2019-09-30  
valid_to: 2020-03-31  
published: 2019-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2EA411A55113  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 1,382,000,000 United States dollar", as of 2019-09-30 (until 2020-03-31). Claim clm_223CF07E8DCB, https://asof.is/claim/clm_223CF07E8DCB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2019, filed 2019-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427219000194/0000014272-19-000194-index.htm (primary, SEC EDGAR 10-Q Q3 FY2019, published 2019-10-31)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 1,328,000,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_223CF07E8DCB](/claim/clm_223CF07E8DCB.md) | [clm_194E6D7B5322](/claim/clm_194E6D7B5322.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.